FDA — authorised 28 October 1982
- Application: BLA018780
- Marketing authorisation holder: LILLY
- Status: supplemented
FDA authorised Humulin R U-500 on 28 October 1982
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 October 1982; FDA has authorised it.
LILLY holds the US marketing authorisation.